Happel David Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
1
Insider Buys Sum
$63,730.70
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of Happel David

According to the SEC Form 4 filings, Happel David, being in a position of

  1. President & CEO at Sagimet Biosciences Inc.,
    оver the last 12 months, has bought 0 shares, and sold 76152 shares for $561,933,
    over all time since 2024-03-26, has bought 12100 shares for $63,731, and sold 141630 shares for $1.16M.

Biography of Happel David

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $561,9332100

Comparison of Insiders on Amount of Buys and Sells

2026-07-20SaleSagimet Biosciences Inc.
SGMT
President & CEO
64,051
0.2131%
$7.76$497,068+36.03%
2026-02-10SaleSagimet Biosciences Inc.
SGMT
President & CEO
12,101
0.0371%
$5.36$64,865+30.5%
2025-07-21SaleSagimet Biosciences Inc.
SGMT
President & CEO
65,478
0.2208%
$9.13$598,115-22.31%
2024-03-26PurchaseSagimet Biosciences Inc.
SGMT
President & CEO
12,100
0.0365%
$5.27$63,731-19.5%
Total: 4
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.